COVID-19 Coronavirus Infection and Trimesters: Is There a Link?

Gulbanu Ganikyzy Shaimerdenova 1 * , Gulzhan Abuova 1, Dana Bekaryssova 2
More Detail
1 Department of Infectious Diseases and Dermatovenerology South Kazakhstan Medical Academy, Shymkent, Kazakhstan
2 Department of Project Management and Commercialization Department, South Kazakhstan Medical Academy, Shymkent, Kazakhstan
* Corresponding Author
J CLIN MED KAZ, In press. https://doi.org/10.23950/jcmk/15792
OPEN ACCESS 102 Views 0 Downloads
Author Contributions: Conceptualization, Sh. G., A. G., B. D.; methodology, A. G; validation B. D., formal analysis, B. D.; investigation, B. D.; resources, B. D.; data curation, B. D.; writing – original draft preparation, Sh. G. and A. G.; writing – review and editing, Sh. G. and A. G.; visualization, A. G.; supervision, Sh. G.; project administration, Sh. G.; funding acquisition, B. D. and Sh. G. All authors have read and agreed to the published version of the manuscript.

ABSTRACT

Objectives: Despite serious challenges, humanity has been able to adapt and take measures to limit the spread of COVID-19 and minimize its negative consequences. This pandemic has emphasized the importance of global collaboration, scientific and medical progress, and raised questions about the need to strengthen health systems and international crisis response mechanisms. Although humanity continues to face new challenges associated with COVID-19, including the emergence of new strains, the development and introduction of vaccines and effective therapeutic agents have raised hope for overcoming the pandemic and creating a more sustainable health system for the future. The aim of our study was to investigate the course of the disease according to trimesters.
Material and methods: We retrospectively analyzed the case histories of women with COVID-19 coronavirus infection treated in the mentioned hospitals between December 2020 and February 2022. The study considered the following parameters according to the trimester of pregnancy: number of previous pregnancies, age, disease severity and presence of comorbidities.
Results: Mild COVID-19 accounted for a smaller proportion of the sample (3.2-13%) due to treatment at home or in outpatient settings. More than half of those hospitalized (209- 51.0%) were admitted in severe condition. Analysis of COVID-19 severity distribution by trimester showed statistically significant differences (p<0.05). Associated diseases were detected in 306 patients, accounting for 74.6% of all cases. Statistically significant differences were found when evaluating comorbidities according to trimester. The main complaints included dry cough (394), weakness (388), sore throat (372), fever (367),
malaise (365) and headache (287).
Conclusions: Infection is more frequently observed in pregnant women in the third trimester, which may be related to the increased frequency of diagnosis in this period. The presence of comorbidities is a factor that increases the severity of the condition.
Keywords: COVID-19, pregnancy, symptoms, trimesters, SARS-Cov-2

CITATION

Shaimerdenova GG, Abuova G, Bekaryssova D. COVID-19 Coronavirus Infection and Trimesters: Is There a Link?. J Clin Med Kaz. 2024. https://doi.org/10.23950/jcmk/15792

REFERENCES

  • Hui DS, I Azhar E, Madani TA, Ntoumi F, Kock R, Dar O, Ippolito G, Mchugh TD, Memisha ZA, Drostena D, Zumla A, Petersena E. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health – The latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020; 91: 264–266. https://doi.org/10.1016/j.ijid.2020.01.009.
  • Gasmi A, Peana M, Pivina L, Srinath S, Gasmi Benahmed A, Semenova Y, Menzel A, Dadar M, Bjørklund G. Interrelations between COVID-19 and other disorders. Clin Immunol. 2021; 224: 108651. https://doi:10.1016/j.clim.2020.108651.
  • Abuova G, Ayazbekov A, Nurkhasimova R, Shaimardenova G, Kulbaeva S, Nurmagambet S. Asymptomatic forms of COVID-19 in pregnant women: long-term consequences. IntJInfectDis. 2022; 116: S46. https://doi.org/10.1016%2Fj.ijid.2021.12.110.
  • Adamyan LV, Vechorko VI, Konysheva OV. Pregnancy and COVID-19: current issues (literature review). Problems of reproduction. 2021; 27(3): 70–77.
  • Romero R. Prenatal medicine: the child is the father of the man. 1996. J Matern Fetal Neonatal Med. 2009; 22(8): 636–639. https://doi.org/10.1080/14767050902784171.
  • Wenling Y, Junchao Q, Xiao Z, Ouyang S. Pregnancy and COVID-19: management and challenges. Revista do Instituto de Medicina Tropical de Sao Paulo. 2020; 62: e62-1–e62-9. https://doi.org/10.1590/s1678-9946202062062.
  • Shaimerdenova GG, Abuova GN, Kulbayeva SN. Features of the course of severe and critical COVID-19 in pregnant women: A prospective cross-sectional study. Int J Reprod BioMed. 2024; 22: 1–6. https://doi:10.18502/ijrm.v22i3.16167.
  • Hariyanto TI, Kwenandar KV, Japar KV, Damay V, Kurniawan A. The efficacy and safety of remdesivir for the treatment of patients with COVID-19: a systematic review and meta-analysis. Anti-Infective Agents. 2021; 19(3): 333–340. http://dx.doi.org/10.2174/22113533MTEwgNTYp4.
  • Asumadu ODK, Boah M, Chirawurah D, Ndago JA, Yakong VN, Kanligi DA, Adokiya MN. Pregnancy outcomes before and during COVID-19 pandemic in Tamale Metropolis, Ghana: A retrospective cohort study. PLoS One. 2024; 19(4): e0302589. https://doi.org/10.1371/journal.pone.0302589.
  • Grasselli G, Zangrillo A, Zanella A, Antonelli M, Cabrini L, Castelli A, Cereda D, Coluccello A, Foti G, Fumagalli R, Iotti G, Latronico N, Lorini L, Merler S, Natalini G, Piatti A, Ranieri MV, Scandroglio AM, Storti E, Cecconi M, Pesenti A. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA. 2020; 323(16): 1574–1581. https://doi.org/10.1001/jama.2020.5394.
  • Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, Anastasia Shchendrygina A, Escher F, Vasa-Nicotera M, Zeiher AM, Vehreschild M, Nagel E. Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19). JAMA Cardiol. 2020; 5(11): 1265–1273. https://doi.org/10.1001/jamacardio.2020.3557.
  • Zhou F, Yu T, Du R, Fan G, Liu Y, LiuZ, Xiang J, Wang Y, Song B, Gu X, Guan L, Wei Y, Li H, Wu X, Xu J, Tu S, Zhang Y, Chen H, Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020; 395: 1054–1062. https://doi.org/10.1016/S0140-6736(20)30566-3.
  • Estimated cumulative excess deaths per 100,000 people during COVID-19. Available at: https://ourworldindata.org/explorers/coronavirus-data-explorer07/16/2022.
  • Liu H, Wang LL, Zhao SJ, Kwak-Kim J, Mor G, Liao AH. Why are pregnant women susceptible to COVID-19? An immunological viewpoint. Journal of Reproductive Immunology. 2020; 139: 103122-1–103122-5. https://doi.org/10.1016/j.jri.2020.103122.
  • Zhu H, Wang L, Fang C, Peng S, Zhang L, Chang G, Xia S, Zhou W. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr. 2020; 9(1): 51–60. https://doi.org/10.21037/tp.2020.02.06.
  • Hong L, Smith N, Keerthy M, Lee-Griffith M, Garcia R, Shaman M, Goyert G. Severe COVID-19 infection in pregnancy requiring intubation without preterm delivery: A case report. Case Rep Womens Health. 2020; 27: e00217. https://doi.org/10.1016/j.crwh.2020.e00217.
  • Garazhayeva L, Gaipov A, Kauysheva A. Assessing the impact of COVID-19 on renal health in recovered patients: a multi-center longitudinal study. J Clin Med Kaz. 2024; 21(2): 31–35. https://doi.org/10.23950/jcmk/14566.
  • Shaimerdenova G. 'Patterns' of COVID-19 Coronavirus Infection in Pregnant Women in Physician Practice. J Clin Med Kaz. 2024; 21(4): 66–70. https://doi.org/10.23950/jcmk/14970.
  • Rodriguez-Morales AJ, Lopez-Echeverri MC, Perez-Raga MF, Quintero-Romero V, Valencia-Gallego V, Galindo-Herrera N, López-Alzate S, Sánchez-Vinasco JD, Gutiérrez-Vargas JJ, Mayta-Tristan P, Husni R, Moghnieh R, Stephan J, Faour W, Tawil S, Barakat H, Chaaban T, Megarbane A, Rizk Y, Sakr R, Escalera-Antezana JP, Alvarado-Arnez LE, Bonilla-Aldana DK, Camacho-Moreno G, Mendoz H, Rodriguez-Sabogal IA, Millán-Oñate J, Lopardo G, Barbosa AN, Cimerman S, do Socorro Souza Chaves T, Orduna T, Lloveras S, Rodriguez-Morales AG, Thormann M, Zambrano PG, Perez C, Sandoval N, Zambran L, Alvarez-Moreno CA, Chacon-Cruz E, Villamil-Gomez WE, Benites-Zapata V, Savio-Larriera E, Cardona-Ospina JA, Risquez A, Forero-Peña DA, Henao-Martínez AF, Sah R, Barboza JJ, León-Figueroa DA, Acosta-España JD, Carrero-Gonzalez CM, Al-Tawfiq JA, Rabaan AA, Leblebicioglu H, Gonzales-Zamora JA, Ulloa-Gutiérrez R.. The global challenges of the long COVID-19 in adults and children. Travel Med Infect Dis. 2023; 54: 102606. https://doi.org/10.1016/j.tmaid.2023.102606.
  • Shaimerdenova GG, Abuova GN, Saltanat S, Baimbetova S, Aidana A. Remdesevir Antiviral Therapy in Pregnant Women with COVID-19. Arch Clin Infect Dis. 2023; 18(1): e132803. https://doi.org/10.5812/archcid-132803.
  • Zhuzzhasarova A, Baesheva D, Azimbaeva N, Smagul M, Nusupbaeva G, Turdalina B, Seidullayeva A, Abdullaev B, Kushugulova A. Epidemiological and Molecular-Genetic Characteristics of the Measles Outbreak in Kazakhstan. Electron J Gen Med. 2022; 19(2): em350. https://doi.org/10.29333/ejgm/11549.
  • Cohen R, Ashman M, Taha MK, Varon E, Angoulvant F, Levy C, Rybak A, Ouldali N, Guiso N, Grimprel E. Pediatric Infectious Disease Group (GPIP) position paper on the immune debt of the COVID-19 pandemic in childhood, how can we fill the immunity gap? Infect Dis Now. 2021; 51(5): 418–423. https://doi:10.1016/j.idnow.2021.05.004.
  • Della Gatta AN, Rizzo R, Pilu G, Simonazzi G. Coronavirus disease 2019 during pregnancy: a systematic review of reported cases. Am J Obstet Gynecol. 2020; 223(1): 36–41. https://doi.org/10.1016/j.ajog.2020.04.013.
  • Tunç Ş, Göklü MR, Oğlak SC. COVID-19 in pregnant women: An evaluation of clinical symptoms and laboratory parameters based on the 3 trimesters. Saudi Med J. 2022; 43(4): 378–385. https://doi.org/10.15537/smj.2022.43.4.20210904.